{"entity":{"type":"insider","cik":"0001465826","url":"/insider/0001465826","json_url":"/insider/0001465826.json","name":"EPIC INVESTMENTS, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":25,"n_filings":17,"first":"2012-03-20","last":"2014-03-17","span_basis":"filed_date"},"name_variants":[{"name":"EPIC INVESTMENTS, LLC","source":"filing","n_filings":17,"first_seen":"2012-03-20","last_seen":"2014-03-17"}],"transactions":[{"id":6517409,"accession":"0001053369-14-000024","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001053369-14-000024","line_url":"/filing/0001053369-14-000024#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465826","owner_name":"EPIC INVESTMENTS, LLC","owner_display_name":"EPIC INVESTMENTS, LLC","owner_url":"/insider/0001465826","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":239367.0,"shares_display":"239,367","price_per_share":0.6016,"price_display":"0.60","price_state":"stated","total_value":144003.1872,"total_display":"144,003.19","total_whole":"144,003","shares_owned_after":67669232.0,"shares_owned_after_display":"67,669,232","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-11","filed_date":"2014-03-17","scope":"insider"},{"id":6467169,"accession":"0001465826-14-000001","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001465826-14-000001","line_url":"/filing/0001465826-14-000001#line-2","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465826","owner_name":"EPIC INVESTMENTS, LLC","owner_display_name":"EPIC INVESTMENTS, LLC","owner_url":"/insider/0001465826","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1051450.0,"shares_display":"1,051,450","price_per_share":0.68,"price_display":"0.68","price_state":"stated","total_value":714986.0,"total_display":"714,986.00","total_whole":"714,986","shares_owned_after":67908599.0,"shares_owned_after_display":"67,908,599","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-07","filed_date":"2014-03-10","scope":"insider"},{"id":6467166,"accession":"0001465826-14-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001465826-14-000001","line_url":"/filing/0001465826-14-000001#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465826","owner_name":"EPIC INVESTMENTS, LLC","owner_display_name":"EPIC INVESTMENTS, LLC","owner_url":"/insider/0001465826","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":773050.0,"shares_display":"773,050","price_per_share":0.8956,"price_display":"0.90","price_state":"stated","total_value":692343.58,"total_display":"692,343.58","total_whole":"692,344","shares_owned_after":68960049.0,"shares_owned_after_display":"68,960,049","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-06","filed_date":"2014-03-10","scope":"insider"},{"id":6426232,"accession":"0001053369-14-000011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001053369-14-000011","line_url":"/filing/0001053369-14-000011#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465826","owner_name":"EPIC INVESTMENTS, LLC","owner_display_name":"EPIC INVESTMENTS, LLC","owner_url":"/insider/0001465826","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":805538.0,"shares_display":"805,538","price_per_share":0.183,"price_display":"0.18","price_state":"stated","total_value":147413.454,"total_display":"147,413.45","total_whole":"147,413","shares_owned_after":69733099.0,"shares_owned_after_display":"69,733,099","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-13","filed_date":"2014-01-17","scope":"insider"},{"id":4800807,"accession":"0001465826-13-000005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001465826-13-000005","line_url":"/filing/0001465826-13-000005#line-2","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465826","owner_name":"EPIC INVESTMENTS, LLC","owner_display_name":"EPIC INVESTMENTS, LLC","owner_url":"/insider/0001465826","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":275000.0,"shares_display":"275,000","price_per_share":0.1255,"price_display":"0.13","price_state":"stated","total_value":34512.5,"total_display":"34,512.50","total_whole":"34,513","shares_owned_after":71004867.0,"shares_owned_after_display":"71,004,867","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-05","filed_date":"2013-12-16","scope":"insider"},{"id":5526148,"accession":"0001053369-13-000059","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001053369-13-000059","line_url":"/filing/0001053369-13-000059#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465826","owner_name":"EPIC INVESTMENTS, LLC","owner_display_name":"EPIC INVESTMENTS, LLC","owner_url":"/insider/0001465826","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":0.1252,"price_display":"0.13","price_state":"stated","total_value":12520.0,"total_display":"12,520.00","total_whole":"12,520","shares_owned_after":71303493.0,"shares_owned_after_display":"71,303,493","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-02","filed_date":"2013-12-04","scope":"insider"},{"id":4387149,"accession":"0001053369-13-000055","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001053369-13-000055","line_url":"/filing/0001053369-13-000055#line-3","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465826","owner_name":"EPIC INVESTMENTS, LLC","owner_display_name":"EPIC INVESTMENTS, LLC","owner_url":"/insider/0001465826","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":0.1212,"price_display":"0.12","price_state":"stated","total_value":3030.0,"total_display":"3,030.00","total_whole":"3,030","shares_owned_after":71403493.0,"shares_owned_after_display":"71,403,493","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-27","filed_date":"2013-11-29","scope":"insider"},{"id":4800799,"accession":"0001465826-13-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001465826-13-000005","line_url":"/filing/0001465826-13-000005#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465826","owner_name":"EPIC INVESTMENTS, LLC","owner_display_name":"EPIC INVESTMENTS, LLC","owner_url":"/insider/0001465826","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23626.0,"shares_display":"23,626","price_per_share":0.1182,"price_display":"0.12","price_state":"stated","total_value":2792.5932,"total_display":"2,792.59","total_whole":"2,793","shares_owned_after":71279867.0,"shares_owned_after_display":"71,279,867","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-26","filed_date":"2013-12-16","scope":"insider"},{"id":4387146,"accession":"0001053369-13-000055","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001053369-13-000055","line_url":"/filing/0001053369-13-000055#line-2","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465826","owner_name":"EPIC INVESTMENTS, LLC","owner_display_name":"EPIC INVESTMENTS, LLC","owner_url":"/insider/0001465826","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":357000.0,"shares_display":"357,000","price_per_share":0.1208,"price_display":"0.12","price_state":"stated","total_value":43125.6,"total_display":"43,125.60","total_whole":"43,126","shares_owned_after":71428493.0,"shares_owned_after_display":"71,428,493","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-26","filed_date":"2013-11-29","scope":"insider"},{"id":4698063,"accession":"0001465826-13-000001","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001465826-13-000001","line_url":"/filing/0001465826-13-000001#line-4","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465826","owner_name":"EPIC INVESTMENTS, LLC","owner_display_name":"EPIC INVESTMENTS, LLC","owner_url":"/insider/0001465826","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21000.0,"shares_display":"21,000","price_per_share":0.117,"price_display":"0.12","price_state":"stated","total_value":2457.0,"total_display":"2,457.00","total_whole":"2,457","shares_owned_after":71824493.0,"shares_owned_after_display":"71,824,493","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-19","filed_date":"2013-11-19","scope":"insider"},{"id":4698057,"accession":"0001465826-13-000001","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001465826-13-000001","line_url":"/filing/0001465826-13-000001#line-3","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465826","owner_name":"EPIC INVESTMENTS, LLC","owner_display_name":"EPIC INVESTMENTS, LLC","owner_url":"/insider/0001465826","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1170000.0,"shares_display":"1,170,000","price_per_share":0.1175,"price_display":"0.12","price_state":"stated","total_value":137475.0,"total_display":"137,475.00","total_whole":"137,475","shares_owned_after":71845493.0,"shares_owned_after_display":"71,845,493","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-18","filed_date":"2013-11-19","scope":"insider"},{"id":9218466,"accession":"0001053369-14-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001053369-14-000005","line_url":"/filing/0001053369-14-000005#line-1","is_derivative":false,"issuer_cik":"0001465826","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001465826","owner_cik":"0001465826","owner_name":"EPIC INVESTMENTS, LLC","owner_display_name":"EPIC INVESTMENTS, LLC","owner_url":"/insider/0001465826","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":253050.0,"shares_display":"253,050","price_per_share":0.1173,"price_display":"0.12","price_state":"stated","total_value":29682.765,"total_display":"29,682.76","total_whole":"29,683","shares_owned_after":72950493.0,"shares_owned_after_display":"72,950,493","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-15","filed_date":"2014-01-06","scope":"insider"},{"id":9218462,"accession":"0001053369-14-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001053369-14-000001","line_url":"/filing/0001053369-14-000001#line-1","is_derivative":false,"issuer_cik":"0001465826","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001465826","owner_cik":"0001465826","owner_name":"EPIC INVESTMENTS, LLC","owner_display_name":"EPIC INVESTMENTS, LLC","owner_url":"/insider/0001465826","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":253050.0,"shares_display":"253,050","price_per_share":0.1173,"price_display":"0.12","price_state":"stated","total_value":29682.765,"total_display":"29,682.76","total_whole":"29,683","shares_owned_after":72950493.0,"shares_owned_after_display":"72,950,493","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-15","filed_date":"2014-01-06","scope":"insider"},{"id":4698053,"accession":"0001465826-13-000001","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001465826-13-000001","line_url":"/filing/0001465826-13-000001#line-2","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465826","owner_name":"EPIC INVESTMENTS, LLC","owner_display_name":"EPIC INVESTMENTS, LLC","owner_url":"/insider/0001465826","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":318050.0,"shares_display":"318,050","price_per_share":0.1173,"price_display":"0.12","price_state":"stated","total_value":37307.265,"total_display":"37,307.26","total_whole":"37,307","shares_owned_after":73015493.0,"shares_owned_after_display":"73,015,493","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-15","filed_date":"2013-11-19","scope":"insider"},{"id":4698050,"accession":"0001465826-13-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001465826-13-000001","line_url":"/filing/0001465826-13-000001#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465826","owner_name":"EPIC INVESTMENTS, LLC","owner_display_name":"EPIC INVESTMENTS, LLC","owner_url":"/insider/0001465826","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":465090.0,"shares_display":"465,090","price_per_share":0.1152,"price_display":"0.12","price_state":"stated","total_value":53578.368,"total_display":"53,578.37","total_whole":"53,578","shares_owned_after":73333543.0,"shares_owned_after_display":"73,333,543","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-14","filed_date":"2013-11-19","scope":"insider"},{"id":4387141,"accession":"0001053369-13-000055","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001053369-13-000055","line_url":"/filing/0001053369-13-000055#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465826","owner_name":"EPIC INVESTMENTS, LLC","owner_display_name":"EPIC INVESTMENTS, LLC","owner_url":"/insider/0001465826","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39000.0,"shares_display":"39,000","price_per_share":0.1225,"price_display":"0.12","price_state":"stated","total_value":4777.5,"total_display":"4,777.50","total_whole":"4,778","shares_owned_after":71785493.0,"shares_owned_after_display":"71,785,493","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-11","filed_date":"2013-11-29","scope":"insider"},{"id":4809000,"accession":"0001053369-13-000051","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001053369-13-000051","line_url":"/filing/0001053369-13-000051#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465826","owner_name":"EPIC INVESTMENTS, LLC","owner_display_name":"EPIC INVESTMENTS, LLC","owner_url":"/insider/0001465826","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":122200.0,"shares_display":"122,200","price_per_share":0.1235,"price_display":"0.12","price_state":"stated","total_value":15091.7,"total_display":"15,091.70","total_whole":"15,092","shares_owned_after":73798633.0,"shares_owned_after_display":"73,798,633","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-06","filed_date":"2013-11-08","scope":"insider"},{"id":4909212,"accession":"0001053369-13-000047","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001053369-13-000047","line_url":"/filing/0001053369-13-000047#line-2","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465826","owner_name":"EPIC INVESTMENTS, LLC","owner_display_name":"EPIC INVESTMENTS, LLC","owner_url":"/insider/0001465826","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":466000.0,"shares_display":"466,000","price_per_share":0.127,"price_display":"0.13","price_state":"stated","total_value":59182.0,"total_display":"59,182.00","total_whole":"59,182","shares_owned_after":73920833.0,"shares_owned_after_display":"73,920,833","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-29","filed_date":"2013-10-30","scope":"insider"},{"id":4909209,"accession":"0001053369-13-000047","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001053369-13-000047","line_url":"/filing/0001053369-13-000047#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465826","owner_name":"EPIC INVESTMENTS, LLC","owner_display_name":"EPIC INVESTMENTS, LLC","owner_url":"/insider/0001465826","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":465000.0,"shares_display":"465,000","price_per_share":0.1295,"price_display":"0.13","price_state":"stated","total_value":60217.5,"total_display":"60,217.50","total_whole":"60,218","shares_owned_after":74386833.0,"shares_owned_after_display":"74,386,833","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-28","filed_date":"2013-10-30","scope":"insider"},{"id":5148188,"accession":"0001053369-13-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001053369-13-000008","line_url":"/filing/0001053369-13-000008#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465826","owner_name":"EPIC INVESTMENTS, LLC","owner_display_name":"EPIC INVESTMENTS, LLC","owner_url":"/insider/0001465826","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":356700.0,"shares_display":"356,700","price_per_share":0.09,"price_display":"0.09","price_state":"stated","total_value":32103.0,"total_display":"32,103.00","total_whole":"32,103","shares_owned_after":12664302.0,"shares_owned_after_display":"12,664,302","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-22","filed_date":"2013-01-25","scope":"insider"},{"id":4575069,"accession":"0001053369-13-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001053369-13-000001","line_url":"/filing/0001053369-13-000001#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465826","owner_name":"EPIC INVESTMENTS, LLC","owner_display_name":"EPIC INVESTMENTS, LLC","owner_url":"/insider/0001465826","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2339000.0,"shares_display":"2,339,000","price_per_share":0.0906,"price_display":"0.09","price_state":"stated","total_value":211913.4,"total_display":"211,913.40","total_whole":"211,913","shares_owned_after":6989002.0,"shares_owned_after_display":"6,989,002","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-11","filed_date":"2013-01-14","scope":"insider"},{"id":7091300,"accession":"0001053369-14-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001053369-14-000007","line_url":"/filing/0001053369-14-000007#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465826","owner_name":"EPIC INVESTMENTS, LLC","owner_display_name":"EPIC INVESTMENTS, LLC","owner_url":"/insider/0001465826","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":531185.0,"shares_display":"531,185","price_per_share":0.15,"price_display":"0.15","price_state":"stated","total_value":79677.75,"total_display":"79,677.75","total_whole":"79,678","shares_owned_after":70538682.0,"shares_owned_after_display":"70,538,682","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-03","filed_date":"2014-01-07","scope":"insider"},{"id":3487034,"accession":"0001053369-12-000009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001053369-12-000009","line_url":"/filing/0001053369-12-000009#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465826","owner_name":"EPIC INVESTMENTS, LLC","owner_display_name":"EPIC INVESTMENTS, LLC","owner_url":"/insider/0001465826","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":561000.0,"shares_display":"561,000","price_per_share":0.0907,"price_display":"0.09","price_state":"stated","total_value":50882.7,"total_display":"50,882.70","total_whole":"50,883","shares_owned_after":9328002.0,"shares_owned_after_display":"9,328,002","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-12-26","filed_date":"2012-12-31","scope":"insider"},{"id":2661161,"accession":"0001053369-12-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001053369-12-000004","line_url":"/filing/0001053369-12-000004#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465826","owner_name":"EPIC INVESTMENTS, LLC","owner_display_name":"EPIC INVESTMENTS, LLC","owner_url":"/insider/0001465826","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":243300.0,"shares_display":"243,300","price_per_share":0.0918,"price_display":"0.09","price_state":"stated","total_value":22334.94,"total_display":"22,334.94","total_whole":"22,335","shares_owned_after":26894442.0,"shares_owned_after_display":"26,894,442","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-12-19","filed_date":"2012-12-21","scope":"insider"},{"id":2694567,"accession":"0001345568-12-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001345568-12-000008","line_url":"/filing/0001345568-12-000008#line-2","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /NV/","issuer_ticker":"ELTP","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001465826","owner_name":"EPIC INVESTMENTS, LLC","owner_display_name":"EPIC INVESTMENTS, LLC","owner_url":"/insider/0001465826","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":85000.0,"shares_display":"85,000","price_per_share":0.1005,"price_display":"0.10","price_state":"stated","total_value":8542.5,"total_display":"8,542.50","total_whole":"8,543","shares_owned_after":63358669.0,"shares_owned_after_display":"63,358,669","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-16","filed_date":"2012-03-20","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":25,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":25,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":25},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001053369","name":"ELITE PHARMACEUTICALS INC /NV/","url":"/issuer/0001053369","role":"Ten percent owner","n_filings":17,"first_seen":"2012-03-20","last_seen":"2014-03-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001465826","retrieved_at":"2026-08-22T21:04:46+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}